» Articles » PMID: 25592038

Hepatocyte Nuclear Factor 4 Alpha Promotes the Invasion, Metastasis and Angiogenesis of Neuroblastoma Cells Via Targeting Matrix Metalloproteinase 14

Overview
Journal Cancer Lett
Specialty Oncology
Date 2015 Jan 17
PMID 25592038
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinase 14 (MMP-14) is the only membrane-anchored MMP that plays critical roles in tumorigenesis and aggressiveness. However, the regulatory mechanisms underlying the high MMP-14 expression in neuroblastoma (NB), a highly malignant tumor in childhood, still remain unclear. Herein, we applied an integrative approach to analyze the public datasets, and identified hepatocyte nuclear factor 4 alpha (HNF4α) as a crucial transcription factor facilitating the MMP-14 expression in NB. In clinical NB tissues, HNF4α was up-regulated and positively correlated with MMP-14 expression, and was an independent prognostic factor for unfavorable outcome of patients. Luciferase reporter and chromatin immunoprecipitation assays indicated that HNF4α directly targeted the binding site within the MMP-14 promoter to facilitate its transcription. Knockdown of HNF4α suppressed the invasion, metastasis and angiogenesis of NB cells in vitro and in vivo. Conversely, ectopic expression of HNF4α promoted the invasion, metastasis and angiogenesis of NB cells. Importantly, restoration of MMP-14 expression prevented the tumor cells from HNF4α-mediated changes in these biological features. Taken together, HNF4α exhibits oncogenic activity that affects the aggressiveness and angiogenesis of NB through activating the transcription of MMP-14.

Citing Articles

Targeted Activation of HNF4α by AMPK Inhibits Apoptosis and Ameliorates Neurological Injury Caused by Cardiac Arrest in Rats.

Zhan H, Zhang Q, Zhang C, Cheng J, Yang Y, Liu C Neurochem Res. 2023; 48(10):3129-3145.

PMID: 37338793 PMC: 10471732. DOI: 10.1007/s11064-023-03957-1.


Activatable Second Near-Infrared Fluorescent Probes: A New Accurate Diagnosis Strategy for Diseases.

Li D, Pan J, Xu S, Fu S, Chu C, Liu G Biosensors (Basel). 2021; 11(11).

PMID: 34821652 PMC: 8615551. DOI: 10.3390/bios11110436.


CHD5 inhibits metastasis of neuroblastoma.

Laut A, Dorneburg C, Furstberger A, Barth T, Kestler H, Debatin K Oncogene. 2021; 41(5):622-633.

PMID: 34789839 PMC: 8799470. DOI: 10.1038/s41388-021-02081-0.


Controversial roles of hepatocyte nuclear receptor 4 α on tumorigenesis.

Wang Z, Zhang Y, Zhang J, Deng Q, Liang H Oncol Lett. 2021; 21(5):356.

PMID: 33747213 PMC: 7968000. DOI: 10.3892/ol.2021.12617.


Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment.

Lv D, Zhou L, Tang H Exp Mol Med. 2021; 53(1):8-18.

PMID: 33462379 PMC: 8080681. DOI: 10.1038/s12276-020-00551-1.